Tag: Hatch-Waxman Act

first generic authorized generic Hatch-Waxman Act generic drug timing pharmaceutical competition

First Generic vs Authorized Generic: Timing of Market Entry in U.S. Drug Market

First generics and authorized generics enter the market differently, with timing that affects drug prices. While first generics wait years to challenge patents, brand companies can launch authorized versions instantly-undercutting competition and slowing price drops.

March 23 2026

generic patent law Hatch-Waxman Act patent litigation pharmaceutical patents Orange Book

Generic Patent Case Law: Landmark Court Decisions That Shape Drug Prices

Landmark court decisions in generic patent law shape how quickly affordable drugs reach patients. Key rulings like Amgen v. Sanofi and Allergan v. Teva are breaking down patent barriers and forcing transparency in drug pricing.

December 17 2025